MedTrace Logo

A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model

NCT02071914 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2020-04-08

Study results available
· View outcomes & findings →

Summary

This study is to evaluate the efficacy of CT-P27 measured by quantitative PCR viral load from nasopharyngeal mucosa, compared to placebo.

Conditions

Interventions

DRUG

CT-P27

Influenza A treatment drug.

DRUG

Placebo

Placebo.

Sponsors & Collaborators

Principal Investigators

  • SuEun Song · Celltrion Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-15
Primary Completion
2014-05-19
Completion
2014-06-19

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02071914 on ClinicalTrials.gov